Journal of Affective Disorders
Volume 63, Issue 1 , Pages 189-199, March 2001

International development of the Quality of Life in Depression Scale (QLDS)

  • S.P McKenna

      Affiliations

    • Galen Research, Manchester Science Park, Enterprise House, Lloyd Street North, Manchester M15 6SE, UK
    • Corresponding Author InformationCorresponding author. Tel.: +44-161-226-4446; fax: +44-161-226-4478
  • ,
  • L.C Doward

      Affiliations

    • Galen Research, Manchester Science Park, Enterprise House, Lloyd Street North, Manchester M15 6SE, UK
  • ,
  • T Kohlmann

      Affiliations

    • Medizinische Universität, Lübeck, Germany
  • ,
  • C Mercier

      Affiliations

    • Douglas Hospital Research Centre, Montreal, Canada
  • ,
  • M Niero

      Affiliations

    • University of Verona, Verona, Italy
  • ,
  • M Paes

      Affiliations

    • Hôpital Psychiatrique Universitaire Ar-Razi, Rabat, Sale, Maroc
  • ,
  • D Patrick

      Affiliations

    • University of Washington, Seattle, WA, USA
  • ,
  • N Ramirez

      Affiliations

    • International University of Catalunya, Barcelona, Spain
  • ,
  • H Thorsen

      Affiliations

    • Copenhagen University, Copenhagen, Denmark
  • ,
  • D Whalley

      Affiliations

    • Galen Research, Manchester Science Park, Enterprise House, Lloyd Street North, Manchester M15 6SE, UK

Received 25 September 1999; received in revised form 31 January 2000; accepted 27 February 2000.

Abstract 

Background: The Quality of Life in Depression Scale (QLDS) employs the needs-based model of quality of life (QoL) and was developed in the UK and The Netherlands as an outcome measure for clinical trials. This paper describes the production and psychometric assessment of nine new language versions for Canada (French and English), Denmark, France, Germany, Italy, Morocco, Spain and the US. Methods: Three adaptation stages were employed; production of conceptually equivalent translations, field-test interviews and assessment of reliability and construct validity by survey of patients with major depression. Results: Few problems were experienced with producing conceptually equivalent translations, except in Morocco. Patients in the field-test interviews found the instrument to have appropriate content and to be easy to complete. Internal consistency and test–retest reliability were excellent for all language versions and scores were found to relate appropriately to measures of depression severity and health status. Limitations: Further investigation is required of the ability of the measure to assess individuals at the extremes of the QoL continuum. Data collected with the Arabic QLDS should not be combined with those from other countries. Conclusions: The QLDS is the first instrument designed to assess QoL in depression based on a coherent model of the construct. Each language version has been shown to be well accepted by respondents and to have excellent psychometric properties. As the instrument is now available in a large number of languages, the QLDS is the QoL instrument of choice for inclusion in clinical trials of interventions for depression.

Keywords:  Depression, Quality of life, Questionnaire, QLDS, Validation

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0165-0327(00)00184-1

Journal of Affective Disorders
Volume 63, Issue 1 , Pages 189-199, March 2001